COMPASS THERAPEUTICS, INC. — Operating Income by Fiscal Year
8 fiscal years, as filed with the SEC; every row links its evidence fact.
Cite as: FACTANKER, https://factanker.com/entity/0f7190d1-f1f2-4a23-9875-78b3c3994f11/serie/operating-income
| Fiscal year | Operating Income | Period | Evidence |
|---|---|---|---|
| FY 2025 | $-72.8M | 2025-01-01 – 2025-12-31 | evidence 0001171843-26-001337 |
| FY 2024 | $-56.6M | 2024-01-01 – 2024-12-31 | evidence 0001171843-25-001106 |
| FY 2023 | $-50.4M | 2023-01-01 – 2023-12-31 | evidence 0001171843-24-001516 |
| FY 2022 | $-41.7M | 2022-01-01 – 2022-12-31 | evidence 0001171843-23-001691 |
| FY 2021 | $-81.9M | 2021-01-01 – 2021-12-31 | evidence 0000950170-22-004156 |
| FY 2020 | $-27.8M | 2020-01-01 – 2020-12-31 | evidence 0001564590-21-011110 |
| FY 2019 | $-32.1k | 2019-04-01 – 2020-03-31 | evidence 0001213900-20-014390 |
| FY 2018 | $-32.8k | 2018-04-01 – 2019-03-31 | evidence 0001213900-19-011850 |
Methodology & sources
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
COMPASS THERAPEUTICS, INC. — all facts · Revenue · Net Income